PhaseBio Exploratory Trial Assesses Potential PAH Treatment
News, PAH News
PhaseBio Pharmaceuticals has enrolled and dosed its first patient with pulmonary arterial hypertension (PAH) in a Phase 1 clinical study assessing the safety, tolerability and hemodynamic response to its PAH ... Read more